Skip to main content
. 2018 Nov 12;12:3879–3883. doi: 10.2147/DDDT.S167149

Figure 2.

Figure 2

Psoriasis Area and Severity Index (PASI) response rates at week 12 in Phase II clinical trial.

Note: Data from Papp et al.12